IncellDx Inc (IncellDx) is a single-cell diagnostic company that develops transformative diagnostic and prognostic clinical patient information technologies. The company detects and monitors life-threatening viral diseases in the areas of cervical cancer, HIV and AIDS, hepatitis, and organ transplant rejection. Its products comprise HIV viral reservoirs probes, HIV tropism probes, HCV viral reservoirs probes, EBV viral reservoirs probes, E6 and E7 mRNA kits, E6 and E7 mRNA probes, fixative permeabilization reagents, core reagents, and HPV positive control and HPV negative control products. The company markets its products across Greece, Spain, China, India and the US. IncellDx is headquartered in Menlo Park, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company IncellDx Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- IncellDx Inc Company Overview
- IncellDx Inc Company Snapshot
- IncellDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- IncellDx Inc - Pipeline Analysis Overview
- IncellDx Inc - Key Facts
- IncellDx Inc - Major Products and Services
- IncellDx Inc Pipeline Products by Development Stage
- IncellDx Inc Pipeline Products Overview
- CCR5 Receptor Occupancy Assay
- CCR5 Receptor Occupancy Assay Product Overview
- COVID-19 - Cytokine Storm Cytokine Panel
- COVID-19 - Cytokine Storm Cytokine Panel Product Overview
- Diagnostic Test - Breast Cancer
- Diagnostic Test - Breast Cancer Product Overview
- Diagnostic Test - Ovarian Cancer
- Diagnostic Test - Ovarian Cancer Product Overview
- HPV OncoTect 3Dx
- HPV OncoTect 3Dx Product Overview
- Machine Learning Algorithm - COVID-19
- Machine Learning Algorithm - COVID-19 Product Overview
- Machine Learning Algorithm - Cytokine/Chemokine Immune Panel
- Machine Learning Algorithm - Cytokine/Chemokine Immune Panel Product Overview
- OncoTect iO Bladder Cancer Kit
- OncoTect iO Bladder Cancer Kit Product Overview
- IncellDx Inc - Key Competitors
- IncellDx Inc - Key Employees
- IncellDx Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- IncellDx Inc, Recent Developments
- Feb 16, 2023: New data links modulation of key immune-related proteins to improvement of specific symptoms in long COVID
- Sep 01, 2022: IncellDx receives CE-IVD marking for incellKINE Long Covid diagnostic test
- Apr 19, 2022: i-Trac is the world’s first integrated health journey wearable and app for mental and physical wellness
- Jan 11, 2022: Frontiers in Immunology publishes new study data from IncellDx supporting a model for understanding long COVID’s cause
- Feb 03, 2021: IncellDx files patent for COVID long hauler index and active COVID-19 severity score
- Jun 18, 2020: IncellDx files patent for CCL5/RANTES utility as a diagnostic, prognostic, and therapeutic biomarker in COVID-19 and other cytokine storm conditions
- Jun 09, 2020: IncellDx’s Next Gen HPV/Cervical Cancer Assay (HPV OncoTect 3Dx) receives clinical approval from Costa Rican Ministry of Health
- Mar 21, 2018: GIMDx and IncellDx Announce Acceleration of Chinese Commercialization of HPV OncoTect Kit
- Jan 17, 2018: Premas, IncellDx Ink India Distribution Agreement
- Mar 30, 2017: IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO Assay
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- IncellDx Inc Pipeline Products and Ongoing Clinical Trials Overview
- IncellDx Inc Pipeline Products by Equipment Type
- IncellDx Inc Pipeline Products by Indication
- IncellDx Inc, Key Facts
- IncellDx Inc, Major Products and Services
- IncellDx Inc Number of Pipeline Products by Development Stage
- IncellDx Inc Pipeline Products Summary by Development Stage
- CCR5 Receptor Occupancy Assay - Product Status
- CCR5 Receptor Occupancy Assay - Product Description
- COVID-19 - Cytokine Storm Cytokine Panel - Product Status
- COVID-19 - Cytokine Storm Cytokine Panel - Product Description
- Diagnostic Test - Breast Cancer - Product Status
- Diagnostic Test - Breast Cancer - Product Description
- Diagnostic Test - Ovarian Cancer - Product Status
- Diagnostic Test - Ovarian Cancer - Product Description
- HPV OncoTect 3Dx - Product Status
- HPV OncoTect 3Dx - Product Description
- Machine Learning Algorithm - COVID-19 - Product Status
- Machine Learning Algorithm - COVID-19 - Product Description
- Machine Learning Algorithm - Cytokine/Chemokine Immune Panel - Product Status
- Machine Learning Algorithm - Cytokine/Chemokine Immune Panel - Product Description
- OncoTect iO Bladder Cancer Kit - Product Status
- OncoTect iO Bladder Cancer Kit - Product Description
- IncellDx Inc, Key Employees
- Glossary
- IncellDx Inc Pipeline Products by Equipment Type
- IncellDx Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Clarient Diagnostic Services, Inc.
- Genomix Biotech Inc
- InterMed PA
